1. Home >
  2. M&A >
  3. Stake Purchase >
  4. Canada >
  5. British Columbia >
  6. Emerald Health Therapeutics Invests In Avricore Health

Investment Summary

Emerald Health Therapeutics Invests In Avricore Health

On November 29, 2017, Emerald Health Therapeutics invested in life science company Avricore Health

Investment Highlights
  • This is Emerald Health Therapeutics’ 1st transaction in the Life Science sector.
  • This is Emerald Health Therapeutics’ 1st transaction in Canada.
  • This is Emerald Health Therapeutics’ 1st transaction in British Columbia.

Investment Summary
Date 2017-11-29
Target Avricore Health
Sector Life Science
Investor(s) Emerald Health Therapeutics
Deal Type Stake Purchase

Target

Avricore Health

Vancouver, British Columbia, Canada
Avricore Health is Western Canada’s first generic prescription and over-the-counter (OTC) product company. Vancpharm's primary mandate is to provide Canadians with affordable Generic Pharmaceuticals and OTC Health care products and consequently become one of the Canada’s leading suppliers of Generic Pharmaceuticals and OTC Health care products. Avricore Health was incorporated in 1996 and is headquartered in Vancouver, Canada.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Emerald Health Therapeutics

Victoria, British Columbia, Canada
Category Company
Sector Medical Products
DESCRIPTION

Emerald Health Therapeutics, Inc. is a health Canada licensed producer of medical cannabis providing safe, efficacious, and clinically proven, high-value cannabis products that enhance the health of Canadians across the country.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Stake Purchase M&A Deals 1 of 1
State: British Columbia M&A 1 of 1
Country: Canada M&A 1 of 1
Year: 2017 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal